Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.

Reduction of colony forming units by rifampicin-isoniazid therapy given 9-17 weeks post-infection was made more pronounced by immunotherapy with a vaccine made of fragmented Mycobacterium tuberculosis cells detoxified and liposomed (RUTI), given on weeks 17, 19 and 21 post-infection, in the murine model of tuberculosis in C57BL/6 and DBA/2 inbred strains. RUTI triggered a Th1/Th2 response, as demonstrated by the production of IgG1, IgG2a and IgG3 antibodies against a wide range of peptides. The histological analysis did not show neither eosinophilia nor necrosis, and granulomatous infiltration was only slightly increased in C57BL/6 mice when RUTI was administered intranasally.

[1]  C. Power,et al.  Mycobacterial Dose Defines the Th1/Th2 Nature of the Immune Response Independently of Whether Immunization Is Administered by the Intravenous, Subcutaneous, or Intradermal Route , 1998, Infection and Immunity.

[2]  Paul C. Rogers,et al.  From Naive to Memory T Cells , 1996, Immunological reviews.

[3]  J. Belisle,et al.  Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry , 1997, Infection and immunity.

[4]  J. Flynn,et al.  Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.

[5]  A. Ariza,et al.  Towards a ‘Human‐like’ Model of Tuberculosis: Intranasal Inoculation of LPS Induces Intragranulomatous Lung Necrosis in Mice Infected Aerogenically with Mycobacterium tuberculosis , 2001, Scandinavian journal of immunology.

[6]  Mahavir Singh,et al.  Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs , 2004, Immunology.

[7]  G. Rook,et al.  Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection , 1997, Infection and immunity.

[8]  W. Bishai,et al.  Exposure to Antibiotics Induces Expression of theMycobacterium tuberculosis sigF Gene: Implications for Chemotherapy against Mycobacterial Persistors , 1999, Antimicrobial Agents and Chemotherapy.

[9]  W. Mcdermott,et al.  Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. , 1966 .

[10]  R. Ulevitch,et al.  A new method for reduction of endotoxin contamination from protein solutions. , 1987, Journal of immunological methods.

[11]  I. Orme,et al.  Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis. , 2002, Tuberculosis.

[12]  W. Rom,et al.  Mycobacterial Antigens Exacerbate Disease Manifestations in Mycobacterium tuberculosis-Infected Mice , 2002, Infection and Immunity.

[13]  I. Orme,et al.  Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic Mode , 2000, Infection and Immunity.

[14]  A. Sampieri,et al.  Analysis of the local kinetics and localization of interleukin‐1α, tumour necrosis‘qc factor‐α and transforming growth factor‐β, during the course of experimental pulmonary tuberculosis , 1997 .

[15]  P. Andersen,et al.  T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis , 1991, Infection and immunity.

[16]  M. Orme.  The latent tuberculosis bacillus (I'll let you know if I ever meet one). , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  E. Julián,et al.  Production of Antibodies against Glycolipids from the Mycobacterium tuberculosis Cell Wall in Aerosol Murine Models of Tuberculosis , 2002, Scandinavian journal of immunology.

[18]  J. Grosset.  Bacteriologic basis of short-course chemotherapy for tuberculosis. , 1980, Clinics in chest medicine.

[19]  A. Cunningham,et al.  Mycobacterial Stationary Phase Induced by Low Oxygen Tension: Cell Wall Thickening and Localization of the 16-Kilodalton α-Crystallin Homolog , 1998, Journal of bacteriology.

[20]  R. Koch.  I. Weitere Mittheilungen über ein Heilmittel gegen Tuberculose , 1890 .

[21]  A. Ariza,et al.  Widespread Bronchogenic Dissemination Makes DBA/2 Mice More Susceptible than C57BL/6 Mice to Experimental Aerosol Infection with Mycobacterium tuberculosis , 2003, Infection and Immunity.

[22]  T. Rabilloud.  Mechanisms of protein silver staining in polyacrylamide gels: A 10‐year synthesis , 1990, Electrophoresis.

[23]  North,et al.  Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype , 1998, Immunology.

[24]  J. Blackwell,et al.  Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. , 1993, Journal of immunology.